好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Language Proficiency is a Marker of Vascular Risk and Ischemic Stroke Severity
Cerebrovascular Disease and Interventional Neurology
P3 - Poster Session 3 (12:00 PM-1:00 PM)
4-015

In primarily English speaking settings, when a patient’s language is discordant from the primary language of the region, does language proficiency predict differences in vascular risk, stroke severity, and the DOC comorbidities: Depression, Obstructive Sleep Apnea and Cognitive impairment?

Ischemic stroke outcomes vary between English and Non-English-speaking populations, reflecting differences in ethnicity, health literacy and socioeconomic status.

Patients with ischemic stroke or TIA between 2012 - 2018 were consecutively recruited across 8 regional stroke centers. Vascular risk factors and stroke severity (mRS) were collected. A validated DOC screening tool was administered. Participants were grouped into: (1) Primary English Speaking (PES), (2) English as a Second Language (ESL) or (3) Non-English Speaking (NES) requiring translation. Binary logistic regression models with age, gender and education as covariates were employed.

6,556  patients met inclusion criteria for the study. We observed a statistically significant difference of diabetes, dyslipidemia, hypertension frequency across our cohorts, with the lowest in the PES cohort and the greatest in the NES cohort. Controlling for covariates, ESL patients had odds of having diabetes, dyslipidemia, and hypertension, that were 29%, 20%, and 37% increased compared to PES. NES patients also had a 35% and 55% increased odds of having dyslipidemia and hypertension. NES patients had a 66% increased odds of having a severe stroke compared to PES patients. Furthermore, ESL and NES patients had two times greater odds of having lower cognitive scores.

In patients with stroke/TIA, language proficiency may identify increased neurovascular risk and potential for severe stroke. While there was no observed relation to depression or OSA, our results indicate that, even with formal translation, lower cognitive scores must be interpreted with caution.  Language proficiency might reflect unique health literacy and socioeconomic needs, as well as a need to improve health education and prevention across language or cultural barriers.  

Authors/Disclosures
Ryan T. Muir, MD (Stroke Prevention Clinic, Clinical Neurosciences, Foothills Medical Centre)
PRESENTER
Dr. Muir has nothing to disclose.
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
Dariush Dowlatshahi, MD (University of Ottawa) Dr. Dowlatshahi has nothing to disclose.
Demetrios J. Sahlas, MD (Hamilton General Hospital) Dr. Sahlas has nothing to disclose.
Gustavo Saposnik, MD (Director, Clinical Outcomes & Decision Neuroscience Research Centre) Dr. Saposnik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Saposnik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIHSS. The institution of Dr. Saposnik has received research support from Roche. The institution of Dr. Saposnik has received research support from Heart and Stroke Foundation of Canada.
Jennifer Mandzia, MD (London Health Sciences Centre) Dr. Mandzia has nothing to disclose.
Leanne Casaubon, MD No disclosure on file
Ayman E. Hassan, MD, FAAN (Thunder Bay Regional Health Science Centre) Dr. Hassan has nothing to disclose.
Yael Perez, MD, PhD No disclosure on file
Brian J. Murray, MD, FAAN The institution of Dr. Murray has received research support from Wake Up Narcolepsy. Dr. Murray has received publishing royalties from a publication relating to health care.
No disclosure on file
Moira Kapral, MD (Toronto General Hospital) The institution of Moira Kapral, MD has received research support from Heart and Stroke Foundation of Canada, Canadian Institutes of Health Research.
No disclosure on file
Amy Y. Yu, MD No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
Richard H. Swartz, BSc MD PhD FRCPC (Sunnybrook Health Sciences Centre) The institution of Dr. Swartz has received research support from Heart and Stroke Foundation of Canada. The institution of Dr. Swartz has received research support from Ontario Brain Institute.